Purity 99% CAS 92339-11-2 Iodixanol Powder Raw Material Iodixanol Pharmaceutical Iodixanol

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Dsung-Iodixanol
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Iodixanol
• Name: Iodixanol Powder
• Appearance: White or off-White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediate
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 92339-11-2
• Mf: C35h44I6n6o15
• MW: 1550.191
• Density: 2.295
• Melting Point: 262-267 C (DEC.)
• Boiling Point: 1250.9 C at 760 Mmhg
• Transport Package: Negotiate
• Specification: 99%
• Trademark: Dsung
• Origin: Xi′an Shaanxi
• Production Capacity: 5000kgs/Month

Product Description

Purity 99% CAS 92339-11-2 Iodixanol Powder Raw Material Iodixanol Pharmaceutical Iodixanol

Product Description

Product Details

Product Name	Iodixanol
CAS No.	92339-11-2
MF	C35H44I6N6O15
MW	1550.191
Appearance and shape	White or off-white powder

Iodixanol, chemical name is 5,5'-((2- hydroxyl -1,3-propane) bis (acetylimide) bis (N,N -2, 3-hydroxy propyl) bis (N,N -2, 3- hydroxy propyl)-2,4,6-triiodol -1,3- phenylphthalamide, CAS No. 92339-11-2, MF: C35H44I6N6O15, MW: 1550.1819, Freely soluble in water, sparingly soluble in methanol, practically insoluble in methylene chloride.  It is suitable for endoconical angiography, but also for intravenous urography, cardio-cerebrovascular angiography.

Application&Function

Iodixanol, developed by Nycomed, Norway, is a new type of non-ionic Xray contrast agent (osmolarity of 290mosmol/kg),  which is the only one in the blood vessel A contrast agent that is isotonic with plasma when applied.Ioxanol is a contrast agent for injection, which is suitable for endoconical angiography, cardio-cerebrovascular angiography and intravenous urography.  It works by binding iodine to blood vessels or tissues to absorb X-rays and create images.  Ioxanol has little effect on cardiovascular parameters and femoral blood flow, but it should be paid attention to when used in elderly patients with renal insufficiency.

Specification